NEWS

2022.06.20

Craif’s Scientific Advisor & Co-Founder Yasui Introduces “Urinary MicroRNA-based Early Cancer Detection Using Nanowire-based Devices” in EUON

  Scientific Advisor & Co-Founder of Craif Inc. (Location: Bunkyo-ku, Tokyo, CEO: Ryuichi Onose, hereinafter referred to as “Craif”) , Takao Yasui, introduced  “Urinary MicroRNA-based Early Cancer Detection Using Nanowire-based Devices” in European Union Observatory for Nanomaterials (EUON) hosted and maintained by the European Chemicals Agency (ECHA).
  In the article, urinary miRNA caught by Nanowire-based Device is said to be a possible promising biomarker to diagnose brain tumors in its early stage. 
  Craif will continue to accelerate R&D, and deliver new ways to optimize cancer treatment to a wide range of people in order to realize our mission of “Ensuring Lifelong Health for Everyone.”

■ Outline of EUON
  EUON is a website funded by the European Commission, and hosted by the European Chemicals Agency (ECHA). It provides useful and interesting information about existing nanomaterials on the EU market for policy makers, consumers, green NGO etc.